Dr Shibo Wu
Co-Founder & CEO
About abYcloud
UK origin. HK landing.
Three UCL PhDs building the AI-native R&D operating layer for antibody therapeutics.
Our story.
The three of us met at UCL — Shibo on AI methods, Chunan on antibody engineering, Lilian on translational immunology — working in the Davson lab on the next generation of structural bioinformatics.
We spun out as abYcloud in the UK to turn that research into an AI-native R&D operating layer for antibody therapeutics.
On 02 August 2024 we incorporated abYcloud (HK) Limited and took our seat at HKSTP InnoCentre. Hong Kong is our R&D orchestration and commercialisation hub — the international interface between UK research and Greater Bay Area execution, and the structural fit for cross-border antibody therapeutic development.
“Trade the execution, not just the idea.”
— Founding team
Founders & advisors.
Three UCL PhDs. Two Davson Professors. One operator.
Founders
Dr Chunan Liu
Co-Founder & CTO
Dr Lilian Denzler
Co-Founder & CSO
Advisors
Mr Takashi Takenoshita
Board Member · Strategic Advisor
Dr John Greenwood
Board Member · Scientific Advisor
Dr Steve Moss
Board Member · Scientific Advisor
WHERE WE ARE
Two offices. One closed loop.
Our AI and wet-lab teams operate in lock-step across continents — design, build, image, repeat.
Connected · uplink active51.51°N · 0.13°W
Coordinates: WGS84 · Equirectangular projection
HQ · EMEA
London
UK · United Kingdom
Registered office, London
- Local
- — local
- hello@abycloud.io
Operations · APAC
Hong Kong
HK · 香港特别行政区
HKSTP InnoCentre, Sha Tin
- Local
- — local
- hk@abycloud.io
How we work.
Evidence over adjectives
Replace 'world-class' with the actual number. Every claim is benchmarked.
Closed loop, not a pipeline
Each campaign sharpens the next. Wet-lab feedback in days, not quarters.
Quietly bilingual
Chinese readers feel the same confidence the English conveys — not literal word-for-word.
Get in touch.
Email us, or book a working session below.